Skip to main content
55th ASAM Annual Conference Main banner
Final Program


Conference Program
Back

Charles McKay, Jr., MD, FACMT

Associate Medical Director
Connecticut Poison Control Center, Connecticut

Charles McKay MD, FACMT is a medical toxicologist at the University of Connecticut School of Medicine, where he serves as Associate Medical Director of the CT Poison Center. His formal training has been in Pathology, Internal Medicine, Emergency Medicine and Medical Toxicology. For over 30 years, he provided toxicology consultation at three hospitals and was the Medical Director of Occupational Health Services and Medical Review Officer for Hartford Hospital and Connecticut Childrens’ Medical Center. He was the Medical Toxicology Fellowship Director at Hartford Hospital/University of Connecticut School of Medicine. He was the Principal Investigator for several laboratory-based clinical studies including comparing urine drug test capabilities and a pilot study for EMS reporting of possible opioid patient encounters to the poison center, which was subsequently expanded to a statewide reporting system by others. He served on the Board of Directors of the American College of Medical Toxicology (ACMT) for 15 years. Under contract to the U.S. Department of Homeland Security (DHS), he led ACMT’s development of a practical toxicology principles course for law enforcement, and participates in ACMT’s contracts and cooperative agreements with the CDC and DHS regarding chemical and environmental exposures. Dr. McKay received a DHS Secretary’s Award for Excellence in 2019. He lectures widely on chemical terrorism and risk communication, including the ACMT Chemical Agents of Opportunity Course, provided to more than 15,000 participants in the last 20 years; and provides medical-legal consultation and education in both civil and criminal matters. Dr. McKay has been a member of the Association of Public Health Laboratories Opioid/Overdose Biosurveillance Task Force (APHL OBTF) since 2018, participating in the development of guidance documents.

Presentation(s):